Evaluation of neutrophil gelatinase-associated lipocalin in normoalbuminuric normotensive type 1 diabetic adolescents

Journal of Pediatric Endocrinology and Metabolism

Volumn 25, Issue 5-6, 2012, Pages 517-523

  Demir, Korcan ^a   Abaci, Ayhan ^a   Küme, Tuncay ^a   Altincik, Ayça ^a   Çatli, Gönül ^a   Böber, Ece ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Adolescent; Ambulatory blood pressure measurement; Microalbuminuria; Neutrophil gelatinase associated lipocalin; Type 1 diabetes

Indexed keywords

ALBUMIN; CREATININE; GLUCOSE; HEMOGLOBIN A1C; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ACUTE PHASE PROTEIN; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

ADOLESCENT; ADOLESCENT DISEASE; ALBUMINURIA; ARTICLE; BLOOD PRESSURE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE URINE LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LABORATORY TEST; MALE; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; BLOOD; DIABETIC NEPHROPATHY; HYPERTENSION; METABOLISM; PHYSIOLOGY; RISK FACTOR; URINE;

ACUTE-PHASE PROTEINS; ADOLESCENT; ALBUMINURIA; BLOOD PRESSURE; CHILD; CREATININE; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; HYPERTENSION; LIPOCALINS; MALE; PROTO-ONCOGENE PROTEINS; RISK FACTORS;

EID: 84865654564     PISSN: 0334018X     EISSN: 21910251     Source Type: Journal    
DOI: 10.1515/jpem-2011-0487     Document Type: Article

References (41)

1. Gill GV, Daousi C, Barnett AH, Bain SC. Chronic kidney disease in long duration type 1 diabetes lasting more than 50 years. Curr Med Res Opin 2009;25:395 - 400.
2. Raile K, Galler A, Hofer S, Herbst A, Dunstheimer D, et al. Diabetic nephropathy in 27,805 children, adolescents, and adults with type 1 diabetes: effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex. Diabetes Care 2007;30:2523 - 8.
3. Svensson M, Nyström L, Schön S, Dahlquist G. Age at onset of childhood-onset type 1 diabetes and the development of end-stage renal disease: a nationwide population-based study. Diabetes Care 2006;29:538 - 42.
4. Bogdanovic R. Diabetic nephropathy in children and adolescents. Pediatr Nephrol 2008;23:507 - 25.
5. Amin R, Widmer B, Prevost AT, Schwarze P, Cooper J, et al. Risk of microalbuminuria and progression to macroal-buminuria in a cohort with childhood onset type 1 diabetes: prospective observational study. Br Med J 2008;336: 697 - 701.
6. Molitch ME, Steffes M, Sun W, Rutledge B, Cleary P, et al. Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study. Diabetes Care 2010;33:1536 - 43.
7. Perkins BA, Ficociello LH, Ostrander BE, Silva KH, Weinberg J, et al. Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes. J Am Soc Nephrol 2007;18:1353 - 61.
8. Haase M, Bellomo R, Haase-Fielitz A. Neutrophil gelatinase-associated lipocalin. Curr Opin Crit Care 2010;16:526 - 32.
9. Wang Y, Lam KS, Kraegen EW, Sweeney G, Zhang J, et al. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin Chem 2007;53:34 - 41.
10. Devarajan P. Review: neutrophil gelatinase-associated lipocalin: a troponin-like biomarker for human acute kidney injury. Nephrology 2010;15:419 - 28.
11. Soni SS, Cruz D, Bobek I, Chionh CY, Nalesso F, et al. NGAL: a biomarker of acute kidney injury and other systemic conditions. Int Urol Nephrol 2010;42:141 - 50.
12. Bolignano D, Lacquaniti A, Coppolino G, Donato V, Fazio MR, et al. Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. Kidney Blood Press Res 2009;32:91 - 8.
13. Zachwieja J, Soltysiak J, Fichna P, Lipkowska K, Stankiewicz W, et al. Normal-range albuminuria does not exclude nephropathy in diabetic children. Pediatr Nephrol 2010;25:1445 - 51.
14. Donaghue KC, Chiarelli F, Trotta D, Allgrove J, Dahl-Jorgensen K. Microvascular and macrovascular complications associated with diabetes in children and adolescents. Pediatr Diabetes 2009;10:195 - 203.
15. Barlow SE, Expert Committee. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics 2007;120(Suppl 4):S164 - 92.
16. Cizmecioǧlu FM, Noyes K, Bath L, Kelnar C. Audit of microalbumin excretion in children with type I diabetes. J Clin Res Pediatr Endocrinol 2009;1:136 - 43.
17. Chang SC. Albuminuria and diabetic nephropathy. Pediatr Endocrinol Rev 2008;5(Suppl 4):974 - 9.
18. Haase-Fielitz A, Haase M, Bellomo R. Instability of urinary NGAL during long-term storage. Am J Kidney Dis 2009;53:564 - 5.
19. McCrindle BW. Assessment and management of hypertension in children and adolescents. Nat Rev Cardiol 2010;7:155 - 63.
20. Urbina E, Alpert B, Flynn J, Hayman L, Harshfield GA, et al. Ambulatory blood pressure monitoring in children and adolescents: recommendations for standard assessment: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the council on cardiovascular disease in the young and the council for high blood pressure research. Hypertension 2008;52:433 - 51.
21. Wei W, Tölle M, Zidek W, van der Giet M. Validation of the Mobil-O-Graph: 24 h-blood pressure measurement device. Blood Press Monit 2010;15:225 - 8.
22. Stergiou GS, Alamara C, Drakatos A, Stefanidis CJ, Vazeou A. Prediction of albuminuria by different blood pressure measurement methods in type 1 diabetes: a pilot study. Hypertens Res 2009;32:680 - 4.
23. Wühl E, Witte K, Soergel M, Mehls O, Schaefer F, German Working Group on Pediatric Hypertension. Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens 2002;20:1995 - 2007.
24. Dost A, Klinkert C, Kapellen T, Lemmer A, Naeke A, et al. Arterial hypertension determined by ambulatory blood pressure profiles: contribution to microalbuminuria risk in a multicenter investigation in 2,105 children and adolescents with type 1 diabetes. Diabetes Care 2008;31:720 - 5.
25. Darcan S, Goksen D, Mir S, Serdaroglu E, Buyukinan M, et al. Alterations of blood pressure in type 1 diabetic children and adolescents. Pediatr Nephrol 2006;21:672 - 6.
26. Chase HP, Marshall G, Garg SK, Harris S, Osberg I. Borderline increases in albumin excretion rate and the relation to glycemic control in subjects with type I diabetes. Clin Chem 1991;37:2048 - 52.
27. Garg SK, Chase HP, Icaza G, Rothman RL, Osberg I, et al. 24-Hour ambulatory blood pressure and renal disease in young subjects with type I diabetes. J Diabetes Complications 1997;11:263 - 7.
28. Perrin NE, Torbjörnsdotter T, Jaremko GA, Berg UB. Risk markers of future microalbuminuria and hypertension based on clinical and morphological parameters in young type 1 diabetes patients. Pediatr Diabetes 2010;11:305 - 13.
29. Wadén J, Forsblom C, Thorn LM, Gordin D, Saraheimo M, et al. A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes. Diabetes 2009;58:2649 - 55.
30. Cavalier E, Bekaert AC, Carlisi A, Legrand D, Krzesinski JM, et al. Neutrophil gelatinase-associated lipocalin (NGAL) determined in urine with the Abbott Architect or in plasma with the Biosite Triage ? The laboratory's point of view. Clin Chem Lab Med 2011;49:339 - 41.
31. Delanaye P, Rozet E, Krzesinski JM, Cavalier E. Urinary NGAL measurement: biological variation and ratio to creatinine. Clin Chim Acta 2011;412:390.
32. Nielsen SE, Schjoedt KJ, Astrup AS, Tarnow L, Lajer M, et al. Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril. Diabet Med 2010;27:1144 - 50.
33. Thrailkill KM, Moreau CS, Cockrell GE, Jo CH, Bunn RC, et al. Disease and gender-specific dysregulation of NGAL and MMP-9 in type 1 diabetes mellitus. Endocrine 2010;37: 336 - 43.
34. Kilpatrick ES, Rigby AS, Atkin SL. The role of blood pressure variability in the development of nephropathy in type 1 diabetes. Diabetes Care 2010;33:2442 - 7.
35. Poniatowski B, Malyszko J, Bachorzewska-Gajewska H, Malyszko JS, Dobrzycki S. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in patients with chronic heart failure and coronary artery disease. Kidney Blood Press Res 2009;32:77 - 80.
36. Mori K, Lee HT, Rapoport D, Drexler IR, Foster K, et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 2005;115:610 - 21.
37. Anwaar I, Gottsäter A, Ohlsson K, Mattiasson I, Lindgärde F. Increasing levels of leukocyte-derived inflammatory mediators in plasma and cAMP in platelets during follow-up after acute cerebral ischemia. Cerebrovasc Dis 1998;8:310 - 7.
38. Mogensen CE, Poulsen PL. Microalbuminuria, glycemic control, and blood pressure predicting outcome in diabetes type 1 and type 2. Kidney Int Suppl 2004;(92):S40 - 1.
39. Nejat M, Hill JV, Pickering JW, Edelstein CL, Devarajan P, et al. Albuminuria increases cystatin C excretion: implications for urinary biomarkers. Nephrol Dial Transpl 2011:1 - 8.
40. Marra G, Cotroneo P, Pitocco D, Manto A, Di Leo MA, et al. Early increase of oxidative stress and reduced antioxidant defenses in patients with uncomplicated type 1 diabetes: a case for gender difference. Diabetes Care 2002;25:370 - 5.
41. Pitocco D, Di Stasio E, Romitelli F, Zaccardi F, Tavazzi B, et al. Hypouricemia linked to an overproduction of nitric oxide is an early marker of oxidative stress in female subjects with type 1 diabetes. Diabetes Metab Res Rev 2008;24:318 - 23.